Engineering Papers⌕ Search

SEARCH · Engineering Papers

Results for “November 2011”

Search indexed NASA NTRS and DOE OSTI research on propulsion, heat transfer, battery materials and energy systems. Follow report and document links to the original sources.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

365 records · Page 21

WE-D-207-01: Background and Clinical Implementation of a Screening Program

In the United States, Lung Cancer is responsible for more cancer deaths than the next four cancers combined. In addition, the 5 year survival rate for lung cancer patients has not improved over the past 40 to 50 years. To combat this deadly disease, in 2002 the National Cancer Institute launched a very large Randomized Control Trial called the National Lung Screening Trial (NLST). This trial would randomize subjects who had substantial risk of lung cancer (due to age and smoking history) into either a Chest X-ray arm or a low dose CT arm. In November 2010, the National Cancer Institute announced that the NLST had demonstrated 20% fewer lung cancer deaths among those who were screened with low-dose CT than with chest X-ray. In December 2013, the US Preventive Services Task Force recommended the use of Lung Cancer Screening using low dose CT and a little over a year later (Feb. 2015), CMS announced that Medicare would also cover Lung Cancer Screening using low dose CT. Thus private and public insurers are required to provide Lung Cancer Screening programs using CT to the appropriate population(s). The purpose of this Symposium is to inform medical physicists and prepare them to support the implementation of Lung Screening programs. This Symposium will focus on the clinical aspects of lung cancer screening, requirements of a screening registry for systematically capturing and tracking screening patients and results (such as required Medicare data elements) as well as the role of the medical physicist in screening programs, including the development of low dose CT screening protocols. Learning Objectives: To understand the clinical basis and clinical components of a lung cancer screening program, including eligibility criteria and other requirements. To understand the data collection requirements, workflow, and informatics infrastructure needed to support the tracking and reporting components of a screening program. To understand the role of the medical physicist in implementing Lung Cancer Screening protocols for CT, including utilizing resources such as the AAPM Protocols and the ACR Designated Lung Screening Center program. UCLA Department of Radiology has an Institutional research agreement with Siemens Healthcare; Dr. McNitt-Gray has been a recipient of Research Support from Siemens Healthcare in the past. Dr. Aberle has been a Member of Advisory Boards for the LUNGevity Foundation (2011-present) and Siemens Medical Solutions. (2013)

60 APPLIED LIFE SCIENCES↗

WE-D-207-02: Capturing Data Elements and the Role of Imaging Informatics

In the United States, Lung Cancer is responsible for more cancer deaths than the next four cancers combined. In addition, the 5 year survival rate for lung cancer patients has not improved over the past 40 to 50 years. To combat this deadly disease, in 2002 the National Cancer Institute launched a very large Randomized Control Trial called the National Lung Screening Trial (NLST). This trial would randomize subjects who had substantial risk of lung cancer (due to age and smoking history) into either a Chest X-ray arm or a low dose CT arm. In November 2010, the National Cancer Institute announced that the NLST had demonstrated 20% fewer lung cancer deaths among those who were screened with low-dose CT than with chest X-ray. In December 2013, the US Preventive Services Task Force recommended the use of Lung Cancer Screening using low dose CT and a little over a year later (Feb. 2015), CMS announced that Medicare would also cover Lung Cancer Screening using low dose CT. Thus private and public insurers are required to provide Lung Cancer Screening programs using CT to the appropriate population(s). The purpose of this Symposium is to inform medical physicists and prepare them to support the implementation of Lung Screening programs. This Symposium will focus on the clinical aspects of lung cancer screening, requirements of a screening registry for systematically capturing and tracking screening patients and results (such as required Medicare data elements) as well as the role of the medical physicist in screening programs, including the development of low dose CT screening protocols. Learning Objectives: To understand the clinical basis and clinical components of a lung cancer screening program, including eligibility criteria and other requirements. To understand the data collection requirements, workflow, and informatics infrastructure needed to support the tracking and reporting components of a screening program. To understand the role of the medical physicist in implementing Lung Cancer Screening protocols for CT, including utilizing resources such as the AAPM Protocols and the ACR Designated Lung Screening Center program. UCLA Department of Radiology has an Institutional research agreement with Siemens Healthcare; Dr. McNitt-Gray has been a recipient of Research Support from Siemens Healthcare in the past. Dr. Aberle has been a Member of Advisory Boards for the LUNGevity Foundation (2011-present) and Siemens Medical Solutions. (2013)

60 APPLIED LIFE SCIENCES↗

WE-D-207-03: CT Protocols for Screening and the ACR Designated Lung Screening Program

In the United States, Lung Cancer is responsible for more cancer deaths than the next four cancers combined. In addition, the 5 year survival rate for lung cancer patients has not improved over the past 40 to 50 years. To combat this deadly disease, in 2002 the National Cancer Institute launched a very large Randomized Control Trial called the National Lung Screening Trial (NLST). This trial would randomize subjects who had substantial risk of lung cancer (due to age and smoking history) into either a Chest X-ray arm or a low dose CT arm. In November 2010, the National Cancer Institute announced that the NLST had demonstrated 20% fewer lung cancer deaths among those who were screened with low-dose CT than with chest X-ray. In December 2013, the US Preventive Services Task Force recommended the use of Lung Cancer Screening using low dose CT and a little over a year later (Feb. 2015), CMS announced that Medicare would also cover Lung Cancer Screening using low dose CT. Thus private and public insurers are required to provide Lung Cancer Screening programs using CT to the appropriate population(s). The purpose of this Symposium is to inform medical physicists and prepare them to support the implementation of Lung Screening programs. This Symposium will focus on the clinical aspects of lung cancer screening, requirements of a screening registry for systematically capturing and tracking screening patients and results (such as required Medicare data elements) as well as the role of the medical physicist in screening programs, including the development of low dose CT screening protocols. Learning Objectives: To understand the clinical basis and clinical components of a lung cancer screening program, including eligibility criteria and other requirements. To understand the data collection requirements, workflow, and informatics infrastructure needed to support the tracking and reporting components of a screening program. To understand the role of the medical physicist in implementing Lung Cancer Screening protocols for CT, including utilizing resources such as the AAPM Protocols and the ACR Designated Lung Screening Center program. UCLA Department of Radiology has an Institutional research agreement with Siemens Healthcare; Dr. McNitt-Gray has been a recipient of Research Support from Siemens Healthcare in the past. Dr. Aberle has been a Member of Advisory Boards for the LUNGevity Foundation (2011-present) and Siemens Medical Solutions. (2013)

60 APPLIED LIFE SCIENCES↗

Completion Report for Well ER-20-12: Corrective Action Units 101 and 102: Central and Western Pahute Mesa

Well ER-20-12 was drilled for the U.S. Department of Energy, Nevada National Security Administration Nevada Field Office in support of the Underground Test Area Activity. The well was drilled from October 2015 to January 2016 as an addition to the Central and Western Pahute Mesa corrective action units 101 and 102 the Phase II drilling program. Well ER-20-12 was identified based on recommendations of the Pahute Mesa Guidance Team as a result of anomalous tritium detections in groundwater samples collected from Well PM-3 in 2011 and 2013. The primary purpose of the well was to provide information on the hydrogeology in the area downgradient of select underground tests on Western Pahute Mesa and define hydraulic properties in the saturated Tertiary volcanic rocks. The main 46.99-centimeter (cm) (18.5-inch [in.]) borehole was drilled to a depth of 765.14 meters (m) (2,510.3 ft) and the hole opened to 66.04 cm (26 in.); followed by the 50.80-cm (20-in.) surface casing, which was installed and sealed with cement; and a piezometer (p4) was set in the Timber Mountain welded-tuff aquifer (TMWTA) between the casing and the open borehole. The borehole was continued with a 46.99-cm (18.5-in.) drill bit to a depth of 1,326.53 m (4,352.16 ft), and an intermediate 24.44-cm (9.625-in.) casing was installed and sealed to 1,188.72 m (3,900.00 ft) A piezometer (p3) was installed across the Calico Hills zeolitic composite unit (CHZCM) (lava-flow aquifer [LFA]) in the annulus of the open borehole. Two additional piezometers were installed and completed between the intermediate casing and the borehole wall, one (p2) in the CHZCM and one (p1) in the Belted Range aquifer (BRA). The piezometers are set to monitor groundwater properties in the completed intervals. The borehole was continued with a 21.59-cm (8.5-in.) drill bit to a total depth of 1,384.80 m (4,543.33 ft), and the main completion 13.97-cm (5.5-in.) casing was installed in the open borehole across the Pre-Belted Range composite unit (PBRCM). Data collected during hole construction include composite drill cutting samples collected every 3.0 m (10 ft), geophysical logs, hydrophysical logs, percussion core samples, water-quality measurements (including tritium), and water-level measurements. The well penetrated 1,384.4 m (4,543.33 ft) of Tertiary volcanic rocks. The stratigraphy and lithology were generally as expected with one noted exception. A thick lava-flow and related ash-flow tuffs were identified as Calico Hills Formation (Th), and no Crater Flat units were noted. Additionally, many of the Thirsty Canyon and Timber Mountain units were thicker than expected. Fluid levels measured in the borehole during drilling are the following: (1) on November 2, 2015, Navarro measured the fluid level in the borehole at a depth of 492.33 m (1,615.25 ft) below ground surface (bgs); (2) Schlumberger and COLOG recorded fluid levels during geophysical logging on November 4 and 5, 2015, at a depth of 492.86 m (1,617 ft) and 492.25 m (1,615 ft) bgs, respectively; and (3) on December 4, 2015, COLOG and Navarro measured fluid level in the 20-in. casing with an open borehole to 1,326.54 m (4,352.16 ft) bgs at 575.77 m (1,889.00 ft) and 574.03 m (1,883.3 ft) bgs, respectively. These and subsequent water-level measurements indicate a potential head difference of greater than 76.2 m (250 ft) for groundwater in aquifers above and below the Upper Paintbrush confining unit (UPCU). As expected, tritium was occasionally measured above the Safe Drinking Water Act limit (20,000 picocuries per liter [pCi/L]). Lab analysis on four bailed samples and taken from the undeveloped well indicate that the tritium activities average approximately 36,545 pCi/L. All Fluid Management Plan (FMP) requirements for Well ER-20-12 were met. Analysis of monitoring samples and FMP confirmatory samples indicate that fluids generated during drilling at ER-20-12 met the FMP criteria for discharge to the lined sump and designated infiltration area. All sanitary and hydrocarbon waste generated was properly handled and disposed of.

54 ENVIRONMENTAL SCIENCES↗

Evolution of Stakeholder Relations at the Mound Laboratory-End of DoE's Mission to the Present - 19551

In November 1989, the same month the Berlin Wall fell, the US Environmental Protection Agency (EPA) placed the Mound Laboratory (Mound Plant or Mound site) in Ohio on the National Priorities List (NPL) due to volatile organic compound contamination in the groundwater. As a result of the Cold War ending, the United States sought to greatly reduce the nation's nuclear weapons arsenal, consolidate the US Department of Energy's (DOE) mission, and close many DOE facilities. In 1991, the City of Miamisburg learned that DOE was planning to close the Mound Laboratory. The city spent two years lobbying in Washington, DC, to keep the facility open; however, that effort was not successful. By 1993, DOE, EPA, and Ohio EPA had signed a Federal Facility Agreement that formalized EPA and Ohio EPA oversight of the DOE environmental cleanup of the Mound NPL site under the Comprehensive Environmental Response, Compensation, and Liability Act (CERCLA). The decontamination and cleanup of the Mound site fell under two federal laws, CERCLA and the Resource Conservation and Recovery Act. DOE, EPA, Ohio EPA, the City of Miamisburg, and other local stakeholders all agreed that the Mound site should be cleaned up to an industrial/commercial land use standard. This would allow the site to transition into a privately owned business park. In 1994, the City of Miamisburg created the nonprofit Miamisburg Mound Community Improvement Corporation (MMCIC) that would own, market, and redevelop the site. The City also chartered the Mound Reuse Committee to act as an independent advisory organization, composed of representatives from the local community and business, government, education, and special interest groups. In 1994, DOE and the MMCIC entered into a lease agreement that facilitated immediate reuse of site buildings that were no longer required by DOE and did not require remediation. In 1995, DOE, EPA, and Ohio EPA developed the Mound 2000 Process to more effectively use CERCLA Removal Action authority to evaluate and remediate, as necessary, disparate areas of the Mound site. The Mound 2000 process divided the site into smaller, more manageable areas that accelerated cleanup and allowed areas to be reused more quickly. All areas of the Mound site were cleaned up to meet the EPA standard for industrial/commercial land use. The CERCLA process included opportunities for the public to review proposed cleanup strategies. Public input on cleanup and reuse included that from local citizens, businesses, Miamisburg City Council, local schools and financial institutions, Ohio EPA, Montgomery County, and the State of Ohio. In 1998, while site cleanup was still in process, DOE agreed to sell the entire Mound property to the MMCIC for $10.00. The site sales agreement accelerated reuse by allowing DOE to offer ownership of discrete land parcels to MMCIC as soon as EPA confirmed those areas met CERCLA standards for property transfer. This allowed the Mound site to become one of the first former DOE weapons sites to transition to reuse as a privately owned and operated community asset. Many other former DOE production facilities require continued federal ownership to protect the integrity of the environmental cleanup. In 2011, the MMCIC changed its name to the Mound Development Corporation (MDC) and continued to transition the site for reuse as part of the Mound Business Park. The MMCIC/MDC is a nonprofit economic development arm of the City of Miamisburg. DOE supported the economic development efforts with grants and matching funds. Individual land parcels were transferred from DOE to the MDC according to the DOE Mound Land Transfer Process. Ownership of parcels was transferred to the MDC via quitclaim deeds with no repair, replacements, or rebuild of areas. Each parcel's quitclaim deed contains the CERCLA institutional controls. To reduce the property tax burden, the Miamisburg City Council passed an ordinance that allowed the City to accept temporary ownership of specific parcels and hold ownership until the MDC could either lease or sell them. With the exception of one 23-acre parcel that includes the Operable Unit 1 area (site of former sanitary landfill), the entire site has been transferred to the MDC. Today, the former Mound Laboratory site is home to the vibrant Mound Business Park operated by the MDC. The site contains numerous buildings with active businesses and multiple areas suitable for new construction. Private companies continue cutting-edge work that carries forward the legacy of more than 50 years of DOE research, development, production, and inspiration from the former Mound Laboratory scientists, engineers, technicians, and support personnel. (authors)

12 MANAGEMENT OF RADIOACTIVE AND NON-RADIOACTIVE W↗